Search research articles
Contact Us
Filters
Showing results (51-60 of 706) with videos related to
Page
of 71
Sort By:
Atherosclerosis
|
January 17, 2013
PANACEA or much a do about nothing: effect of a statin and ezetimibe on postprandial lipaemia and endothelial function in the metabolic syndrome
Dick C Chan, Gerald F Watts
Lancet (London, England)
|
October 6, 2014
Familial hypercholesterolaemia: PCSK9 inhibitors are coming
Raul D Santos, Gerald F Watts
Current Atherosclerosis Reports
|
January 7, 2023
The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder
Wann Jia Loh, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity
|
December 5, 2022
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?
Wann Jia Loh, Gerald F Watts
Clinical Chemistry
|
April 30, 2008
Estimating LDL ApoB: infomania or clinical advance?
John R Burnett, Gerald F Watts
Heart, Lung & Circulation
|
October 12, 2016
Under-Recognised and Underestimated: The Cardiovascular Health Burden of Familial Hypercholesterolaemia
Alistair W Vickery, Gerald F Watts
Lancet (London, England)
|
August 14, 2012
Balancing the cardiometabolic benefits and risks of statins
Gerald F Watts, Esther M Ooi
Atherosclerosis
|
June 15, 2012
HSV-2 and atherosclerosis: adding to the alphabet soup of coronary risk in HIV infection
Gerard T Chew, Gerald F Watts
Lancet (London, England)
|
October 9, 2018
Lipoprotein(a): lodestar for future clinical trials
Gerald F Watts, Michael B Boffa
Endocrinology and Metabolism Clinics of North America
|
August 13, 2022
The Inherited Hypercholesterolemias
Wann Jia Loh, Gerald F Watts
Page
of 71
Search research articles
Search
Showing results (51-60 of 706) with videos related to
Sort By:
Page
of 71
Atherosclerosis
|
January 17, 2013
PANACEA or much a do about nothing: effect of a statin and ezetimibe on postprandial lipaemia and endothelial function in the metabolic syndrome
Dick C Chan, Gerald F Watts
Lancet (London, England)
|
October 6, 2014
Familial hypercholesterolaemia: PCSK9 inhibitors are coming
Raul D Santos, Gerald F Watts
Current Atherosclerosis Reports
|
January 7, 2023
The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder
Wann Jia Loh, Gerald F Watts
Current Opinion in Endocrinology, Diabetes, and Obesity
|
December 5, 2022
Detection strategies for elevated lipoprotein(a): will implementation let the genie out of the bottle?
Wann Jia Loh, Gerald F Watts
Clinical Chemistry
|
April 30, 2008
Estimating LDL ApoB: infomania or clinical advance?
John R Burnett, Gerald F Watts
Heart, Lung & Circulation
|
October 12, 2016
Under-Recognised and Underestimated: The Cardiovascular Health Burden of Familial Hypercholesterolaemia
Alistair W Vickery, Gerald F Watts
Lancet (London, England)
|
August 14, 2012
Balancing the cardiometabolic benefits and risks of statins
Gerald F Watts, Esther M Ooi
Atherosclerosis
|
June 15, 2012
HSV-2 and atherosclerosis: adding to the alphabet soup of coronary risk in HIV infection
Gerard T Chew, Gerald F Watts
Lancet (London, England)
|
October 9, 2018
Lipoprotein(a): lodestar for future clinical trials
Gerald F Watts, Michael B Boffa
Endocrinology and Metabolism Clinics of North America
|
August 13, 2022
The Inherited Hypercholesterolemias
Wann Jia Loh, Gerald F Watts
Page
of 71